CEACAM5 and gastric carcinoma: A recent study demonstrated that nectin-1:scFv anti-CEA adapter (soluble bridging molecule) enhances transduction efficacy and produces three times reduction in tumor volume when compared to no adaptor control animals bearing human gastric carcinoma MKN45 tumors in the flank.